MedTrace Logo

HD Mapping of Atrial Fibrillation in Asia Pacific

NCT04022954 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-03-29

Study results available
· View outcomes & findings →

Summary

The aim of this study is to quantify and characterize the outcomes of radiofrequency (RF) ablation after, and the utility of, electroanatomical mapping with the market-released HD mapping catheters Inquiry™ AFocusII™ Double Loop and Advisor™ HD Grid, Sensor Enabled™ with the EnSite Cardiac Mapping System and the EnSite Automap module in subjects with AF in the real-world environment of the Asian population.

Conditions

  • Paroxysmal Atrial Fibrillation
  • Persistent Atrial Fibrillation

Interventions

DEVICE

Catheter ablation

Inquiry AFocusII Double Loop and Advisor HD Grid, Sensor Enabled

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Kristin Ruffner, PhD · EP Program Director

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-11
Primary Completion
2021-08-13
Completion
2021-08-13

Countries

  • China
  • Hong Kong
  • Japan
  • South Korea
  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04022954 on ClinicalTrials.gov